Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →You can get a weight loss prescription online through a licensed telehealth provider. After a medical intake and clinician review, eligible patients, often BMI 30+ or BMI 27+ with a weight-related condition, may receive an FDA-approved medication or, when legally allowed, a compounded GLP-1 from a licensed pharmacy.[1][2][3]
Can you actually get a weight loss prescription online?
Yes. Weight loss prescriptions online can be appropriate when a licensed clinician reviews your history, confirms that the medicine fits your health needs, and sends the prescription to a licensed pharmacy. For many anti-obesity medicines, FDA labeling uses BMI 30+ or BMI 27+ with at least one weight-related condition as a common starting point for eligibility.[1][2][7]
Online care does not mean automatic approval. A clinician may need recent lab results, a blood pressure reading, a medication list, pregnancy status, and details about past pancreatitis, gallbladder disease, eating disorders, diabetes, kidney disease, or thyroid cancer risk before deciding what is safe.[1][2][8]
What telehealth can and can't do
Telehealth can collect your medical history, review photos or measurements when needed, order labs, prescribe medication when appropriate, and plan follow-up care. It cannot replace emergency care, and it should not skip safety screening just because the visit is online.[8]
Some medicines have extra legal limits. The Ryan Haight Act generally requires at least one in-person evaluation before prescribing controlled substances by the internet, unless an exception applies; federal telemedicine flexibilities have been extended while agencies work on updated rules.[9]
What a legitimate online visit looks like
- You complete a health intake that asks about height, weight, medications, allergies, medical history, pregnancy plans, and prior weight loss treatments.
- A licensed clinician reviews your information before any prescription is written.
- The provider explains benefits, side effects, contraindications, alternatives, cost, and follow-up needs.
- The prescription is sent to a licensed retail, mail-order, or compounding pharmacy.
- You have a way to ask questions and report side effects after starting treatment.
Which weight loss medications can be prescribed online?
Several medication types may be prescribed online after a clinician review. Semaglutide and tirzepatide are common search terms, but the right choice depends on medical history, FDA status, cost, side effects, and contraindications. No option is risk-free, and no medication guarantees a specific result; individual results vary.[1][2][10][11]
GLP-1 injections: semaglutide and tirzepatide
Wegovy (semaglutide, a GLP-1 receptor agonist; also available as compounded semaglutide through some licensed 503A pharmacies when legally allowed) is FDA-approved for chronic weight management in eligible adults and certain adolescents. In a large trial, semaglutide with lifestyle support led to greater average weight loss than placebo, but nausea, diarrhea, vomiting, constipation, gallbladder events, pancreatitis warnings, kidney injury warnings, and a boxed warning for thyroid C-cell tumors are part of the risk discussion.[1][10]
Zepbound (tirzepatide, a GIP/GLP-1 dual agonist; also available as compounded tirzepatide through some licensed 503A pharmacies when legally allowed) is FDA-approved for chronic weight management in eligible adults. In a large trial, tirzepatide with lifestyle support led to greater average weight loss than placebo, but common side effects included nausea, diarrhea, vomiting, and constipation, and the label includes warnings about thyroid C-cell tumors, pancreatitis, gallbladder disease, kidney injury, and severe gastrointestinal disease.[2][11]
Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not weight loss. If a clinician prescribes Ozempic or Mounjaro mainly for weight loss, that is off-label use; it should be discussed clearly, including benefits, risks, alternatives, and insurance limits.[4][5]
Oral GLP-1s: oral semaglutide and orforglipron
Oral semaglutide is FDA-approved for type 2 diabetes under the brand Rybelsus, not for chronic weight management. Higher-dose oral semaglutide has been studied for weight loss, with meaningful average weight loss in trials, but stomach side effects were common and the approved diabetes label carries the same thyroid C-cell tumor boxed warning as other semaglutide products.[12][13]
Orforglipron (an oral GLP-1 receptor agonist; sometimes searched with the brand name Foundayo) has been studied for obesity, but it is not FDA-approved for weight loss unless the FDA has issued a newer approval after this article is read. Trial data suggest weight-loss potential, but gastrointestinal side effects were common, and long-term safety, contraindications, and final labeling depend on FDA review.[14]
Older options: liraglutide, phentermine-topiramate, naltrexone-bupropion, and orlistat
Saxenda (liraglutide, a GLP-1 receptor agonist) is FDA-approved for chronic weight management in eligible adults and certain adolescents. It can help some patients lose weight, but it is a daily injection and has similar GLP-1 safety issues, including stomach side effects and a boxed warning for thyroid C-cell tumors.[7]
Qsymia (phentermine-topiramate) is FDA-approved for chronic weight management, but phentermine is a controlled substance. It may raise heart rate, is contraindicated in pregnancy because of birth-defect risk, and may require in-person or telemedicine-rule review depending on current federal and state rules.[15][9]
Contrave (naltrexone-bupropion) is FDA-approved for chronic weight management. It can help some adults lose weight, but it carries a boxed warning about suicidal thoughts and behaviors in young adults, and it is contraindicated with seizure disorders, chronic opioid use, and uncontrolled high blood pressure.[16]
Xenical and Alli (orlistat) reduce dietary fat absorption and are FDA-approved for weight management in prescription and over-the-counter forms. They may cause oily stools, urgency, and fat-soluble vitamin issues, and rare severe liver injury has been reported.[17]
Compounded semaglutide and tirzepatide through 503A pharmacies
Compounded semaglutide and compounded tirzepatide are not FDA-approved products. A licensed 503A compounding pharmacy may prepare a patient-specific medication when legal conditions are met, but the FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.[6]
Compounded GLP-1s may be considered when clinically appropriate and legally available, but patients should ask whether the pharmacy is licensed, whether the active ingredient is the correct form, whether potency and sterility testing are performed, and how side effects are monitored. The same GLP-1-type risks, including stomach side effects and important contraindications, still matter.[1][2][6]
Who qualifies for an online weight loss prescription?
For many FDA-approved anti-obesity medicines, eligibility starts with BMI. Labels commonly include adults with BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.[1][2][7][15][16]
BMI is not the only factor. A clinician also looks at age, pregnancy status, current medicines, past side effects, eating disorder history, substance use history, kidney or liver disease, diabetes medicines, and whether the medication’s risks fit your health profile.[1][2][8]
BMI thresholds and weight-related conditions
- BMI 30 or higher: often meets the weight criterion for FDA-approved chronic weight management medications.[1][2]
- BMI 27 or higher plus a condition: may qualify when a weight-related condition is present, such as hypertension, dyslipidemia, or type 2 diabetes.[1][2]
- Adolescents: only certain products have pediatric indications, and eligibility depends on age, BMI percentile, and label details.[1][7]
- Type 2 diabetes: may change medication choice, insurance coverage, and monitoring needs.[4][5]
When a clinician may decline to prescribe
A clinician may decline a GLP-1 or GIP/GLP-1 prescription if you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy, severe gastrointestinal disease, a concerning pancreatitis history, unsafe medication interactions, or missing safety information.[1][2]
A clinician may also suggest a different path if an in-person exam is needed, symptoms suggest an urgent problem, a controlled substance rule applies, or the requested medicine is not appropriate for the stated goal.[8][9]
How much do online weight loss prescriptions cost?
Costs vary by medication, pharmacy, insurance, visit fee, labs, and follow-up. Brand GLP-1 list prices are often around $1,000 or more per month before insurance or savings programs, while compounded GLP-1 pricing varies by provider and pharmacy and is not the same as an FDA-approved product.[18][19][6]
| Option | FDA status for weight loss | Typical cost factors | Safety notes |
|---|---|---|---|
| Wegovy (semaglutide) | FDA-approved for chronic weight management in eligible patients.[1] | Brand list price, insurance coverage, prior authorization, savings card rules, visit fees.[18] | GI side effects are common; boxed warning for thyroid C-cell tumors; contraindicated with personal/family history of MTC or MEN 2.[1] |
| Zepbound (tirzepatide) | FDA-approved for chronic weight management in eligible adults.[2] | Brand list price, insurance coverage, prior authorization, savings card rules, visit fees.[19] | GI side effects are common; boxed warning for thyroid C-cell tumors; contraindicated with personal/family history of MTC or MEN 2.[2] |
| Ozempic or Mounjaro | FDA-approved for type 2 diabetes, not weight loss; weight-loss use is off-label.[4][5] | Insurance may deny coverage if prescribed without a diabetes indication; cash prices can be high. | Similar GLP-1 or GIP/GLP-1 risks; off-label use needs clear clinician review.[4][5] |
| Compounded semaglutide or compounded tirzepatide | Not FDA-approved products; may be dispensed by licensed 503A pharmacies when legal requirements are met.[6] | Cash-pay pricing, pharmacy fees, clinician follow-up, labs, and shipping may apply. | FDA does not review compounded drugs for safety, effectiveness, or quality before dispensing; ask about sourcing and testing.[6] |
| Older oral options such as Contrave or orlistat | FDA-approved for weight management in eligible patients, depending on product.[16][17] | Often lower cash cost than brand GLP-1s, but coverage varies. | Different side effects and contraindications; not appropriate for every patient.[16][17] |
Brand GLP-1 list prices vs. manufacturer savings
Brand list price is not always what a patient pays. Insurance, deductibles, prior authorization, employer plan rules, and manufacturer savings programs can change the final cost. Savings programs often have eligibility limits and may not apply to government insurance.[18][19]
Compounded GLP-1 pricing
Compounded GLP-1 pricing is usually cash-pay and may bundle the visit, follow-ups, medication, supplies, and shipping. Because compounded semaglutide and compounded tirzepatide are not FDA-approved products, lower cost should not be the only factor; pharmacy licensing, ingredient source, sterility practices, and clinician follow-up matter.[6]
Cash-pay vs. insurance coverage
Cash-pay programs may be simpler to start, but they can be expensive over time. Insurance may lower cost, but it often requires proof of BMI, a weight-related condition, prior lifestyle attempts, step therapy, or renewal documentation.[1][2]
3-min quiz
Compare your options with a clinician
If you are considering an online weight loss prescription, a licensed clinician can review your health history, medication options, side effects, and pharmacy choices before anything is prescribed.
How does the online prescription process work step by step?
A legitimate online process usually has 4 steps: intake, clinician review, pharmacy dispensing, and follow-up. Each step is there to confirm that the medication is appropriate, reduce avoidable risk, and adjust the plan if side effects or cost problems arise.[8]
1. Intake and medical history
You share height, weight, health goals, medical conditions, current medicines, allergies, pregnancy status, and past weight loss treatments. Some providers also ask for labs, a blood pressure reading, or recent records before prescribing.[8]
2. Clinician video or asynchronous review
Some services use a video visit. Others use secure messaging or asynchronous review, where a clinician reviews your intake and asks follow-up questions. Either way, a licensed clinician should make the prescribing decision.[8]
3. Prescription, pharmacy dispensing, and delivery
If prescribed, the medication may go to a retail pharmacy, mail-order pharmacy, or licensed compounding pharmacy. For compounded GLP-1s, patients should confirm the pharmacy is licensed and understand that compounded products are not FDA-approved.[6]
4. Follow-ups and dose adjustments
Follow-ups help track side effects, weight trend, blood pressure, blood sugar when relevant, and whether the plan still fits. GLP-1 labels use gradual titration schedules to improve tolerability, but any dose change should be decided by the prescriber, not self-directed.[1][2]
How do you choose a safe online weight loss provider?
A safe provider makes the medical review clear before payment or prescribing. Legitimate telehealth clinics should use licensed clinicians, licensed pharmacies, transparent pricing, and ongoing follow-up, not a one-click checkout for prescription medicine.[8]
Signs of a legitimate telehealth clinic
- Clinicians are licensed in the state where you receive care.
- The intake asks about contraindications, pregnancy, medication interactions, and past medical history.
- The provider explains FDA status, including when use is off-label or compounded.
- The pharmacy is named or can be verified as licensed.
- Side effects, urgent symptoms, and follow-up plans are explained.
- Pricing separates visit fees, medication cost, labs, shipping, and membership fees.
Red flags to avoid
- No clinician review before purchase.
- Promises of guaranteed weight loss or fixed results.
- No screening for thyroid cancer history, MEN 2, pregnancy, pancreatitis, gallbladder disease, or medication interactions.
- Unclear pharmacy source or claims that compounded drugs are FDA-approved.
- Pressure to buy quickly or pay before basic eligibility is reviewed.
- No clear way to contact the care team about side effects.
Questions to ask before you pay
- 1Who reviews my intake, and are they licensed in my state?
- 2Which medication options do you prescribe, and which are FDA-approved for weight loss?
- 3If compounded medication is offered, which licensed pharmacy dispenses it?
- 4What is included in the monthly price?
- 5How are side effects handled after the prescription is sent?
- 6What happens if I do not qualify?
How to get a weight loss prescription through Chia
Chia is one option among licensed telehealth providers for patients seeking a clinician-reviewed path to weight loss medication, including compounded GLP-1 options when clinically appropriate and legally available through licensed 503A pharmacy partners. The goal is not automatic approval; it is a medical review that weighs benefits, side effects, contraindications, cost, and follow-up needs.[6][8]
Clinician-reviewed intake
A clinician-reviewed intake should confirm BMI, weight-related conditions, medical history, current medicines, allergies, pregnancy status, and contraindications. For GLP-1 or GIP/GLP-1 medicines, that includes screening for personal or family history of medullary thyroid carcinoma or MEN 2, as well as pancreatitis and gallbladder risks.[1][2]
Compounded GLP-1 options and pricing
If compounded semaglutide or compounded tirzepatide is discussed, the provider should state that these are not FDA-approved products. Patients should be told which licensed pharmacy is used, what testing and quality checks are performed, what the total price includes, and how follow-up care works.[6]
A note on access
Access should never come before safety. The right online program is the one that checks eligibility, explains trade-offs, uses licensed pharmacy channels, and gives you a clear way to get help if side effects happen.[8]
Frequently asked questions
Possibly, but Ozempic is FDA-approved for type 2 diabetes, not weight loss. If a clinician prescribes Ozempic mainly for weight loss, that is off-label use and should include a clear discussion of risks, benefits, alternatives, insurance limits, and side effects.[4]
There is no single cheapest option for everyone. Brand GLP-1 prices depend on list price, pharmacy, savings programs, and cash-pay rules. Compounded GLP-1s may cost less in some cash-pay programs, but they are not FDA-approved products and should only be used through licensed providers and pharmacies when legally allowed.[6][18][19]
Compounded semaglutide can be legal when it meets federal and state compounding rules and is prepared by a properly licensed pharmacy for an appropriate patient-specific need. It is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before dispensing.[6]
Timing varies. Some telehealth reviews happen quickly, while others need labs, records, pharmacy checks, or follow-up questions first. A prescription should only be issued after a licensed clinician confirms that the medication is appropriate for you.[8]
Often, no in-person visit is needed for non-controlled weight loss medications if the clinician can safely evaluate you by telehealth. Controlled substances, such as phentermine-containing products, may have extra federal and state rules under the Ryan Haight Act and current telemedicine policies.[9]
AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health, but a licensed clinician still decides whether any medication is appropriate.
3-min quiz
Learn about online weight loss medication options
A clinical evaluation can help you understand whether a GLP-1, another FDA-approved medication, or a compounded option is appropriate for your health history and goals.
References
- 1.U.S. Food and Drug Administration, Wegovy (semaglutide) injection prescribing information, 2024.
- 2.U.S. Food and Drug Administration, Zepbound (tirzepatide) injection prescribing information, 2023.
- 3.U.S. Food and Drug Administration, FDA approves new drug treatment for chronic weight management, first since 2014, 2021.
- 4.U.S. Food and Drug Administration, Ozempic (semaglutide) injection prescribing information, 2023.
- 5.U.S. Food and Drug Administration, Mounjaro (tirzepatide) injection prescribing information, 2023.
- 6.U.S. Food and Drug Administration, Compounding and the FDA: Questions and answers, 2024.
- 7.U.S. Food and Drug Administration, Saxenda (liraglutide) injection prescribing information, 2023.
- 8.American Medical Association, Telehealth implementation playbook, 2022.
- 9.Drug Enforcement Administration and U.S. Department of Health and Human Services, Third temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications, Federal Register, 2024.
- 10.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al., Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine, 2021.
- 11.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al., Tirzepatide once weekly for the treatment of obesity, New England Journal of Medicine, 2022.
- 12.U.S. Food and Drug Administration, Rybelsus (semaglutide) tablets prescribing information, 2024.
- 13.Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, et al., Oral semaglutide 50 mg taken once per day in adults with overweight or obesity: the OASIS 1 randomized clinical trial, The Lancet, 2023.
- 14.Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, et al., Daily oral GLP-1 receptor agonist orforglipron for adults with obesity, New England Journal of Medicine, 2023.
- 15.U.S. Food and Drug Administration, Qsymia (phentermine and topiramate extended-release) prescribing information, 2022.
- 16.U.S. Food and Drug Administration, Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets prescribing information, 2021.
- 17.U.S. Food and Drug Administration, Xenical (orlistat) capsules prescribing information, 2022.
- 18.Novo Nordisk, Wegovy pricing and savings information, 2025.
- 19.Eli Lilly and Company, Zepbound pricing, savings, and coverage information, 2025.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
